GridAI Technologies (GRDX) Dividends payables (2020 - 2026)
GridAI Technologies' (GRDX) quarterly Dividends payables came in at $1.8 million in Q2 2026, up 1008.29% on a YoY basis from $163428.0 in Q2 2025, and up 9.92% quarter-over-quarter from $1.6 million in Q4 2025.
Analysis
GridAI Technologies (GRDX) Dividends payables (2020 - 2026) Analysis & Trends
GridAI Technologies (GRDX) has reported Dividends payables for 7 consecutive years, with $1.8 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Dividends payables rose 1008.29% year-over-year to $1.8 million; the trailing twelve-month figure through Jun 2026 stood at $1.8 million (up 1008.29% YoY), and the FY2025 full-year result was $1.6 million, up 25.73% from the prior year.
- Dividends payables improved to $1.8 million in Q2 2026 per GRDX's latest filing, from $1.6 million in the prior quarter.
- Across five years, Dividends payables topped out at $1.8 million in Q2 2026 and bottomed at $66144.0 in Q1 2024.
- Historically, Dividends payables has averaged $656299.8 across 5 years, with a median of $231047.0 in 2023.
- The sharpest annual moves came in 2022 and 2025: Dividends payables sank 55.58% in 2022, then surged 2004.26% in 2025.
- Over 5 years, Dividends payables stood at $761488.0 in 2022, then soared by 40.46% to $1.1 million in 2023, then increased by 22.53% to $1.3 million in 2024, then rose by 25.73% to $1.6 million in 2025, then advanced by 9.92% to $1.8 million in 2026.
- According to Business Quant data, Dividends payables over the past three periods registered $1.8 million, $1.6 million, and $1.6 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.74 Bn | 192.75 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.96 Bn | 176.78 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 131.20 Bn | 123.35 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.05 Bn | 74.05 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.28 Bn | 55.10 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.67 Bn | 48.54 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.08 Bn | 29.78 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.91 Bn | 30.62 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.22 Bn | 29.22 Bn | 1.16 Mn | - |
| 10 | GridAI Technologies | 18.97 Mn | 18.97 Mn | -36,514.00 | 1.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.81 Mn |
| Dec 31, 2025 | 1.65 Mn |
| Sep 30, 2025 | 1.56 Mn |
| Jun 30, 2025 | 163,428.00 |
| Mar 31, 2025 | 1.39 Mn |
| Dec 31, 2024 | 1.31 Mn |
| Sep 30, 2024 | 188,834.00 |
| Jun 30, 2024 | 104,202.00 |
| Mar 31, 2024 | 66,144.00 |
| Dec 31, 2023 | 1.07 Mn |
| Sep 30, 2023 | 231,047.00 |
| Jun 30, 2023 | 181,755.00 |
| Mar 31, 2023 | 87,431.00 |
| Dec 31, 2022 | 761,488.00 |
| Sep 30, 2022 | 298,195.00 |
| Jun 30, 2022 | 187,917.00 |
| Mar 31, 2022 | 90,792.00 |
| Dec 31, 2021 | 465,361.00 |
| Sep 30, 2021 | 349,132.00 |
| Jun 30, 2021 | 231,043.00 |